医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

A.M. Best Assigns Credit Ratings to Ping An Health Insurance Company of China, Ltd.

2017年08月03日 AM03:10
このエントリーをはてなブックマークに追加


 

HONG KONG

A.M. Best has assigned a Financial Strength Rating of A- (Excellent) and a Long-Term Issuer Credit Rating of “a-” to Ping An Health Insurance Company of China, Ltd. (Ping An Health) (China). The outlook assigned to these Credit Ratings (ratings) is stable.

Ping An Health is a specialized health insurer that provides group and individual health insurance products in its domestic market. Headquartered in Shanghai, the company has branches in Beijing, Shanghai, Tianjin, Guangdong, Shenzhen, Liaoning, Jiangsu and Zhejiang. Ping An Health is a joint venture between Ping An Insurance (Group) Company of China, Ltd. (Ping An Group) (71.26% share) and Discovery, Ltd. (24.99% share), whose subsidiary, Discovery Health (Proprietary) Limited, is a market leader in South Africa’s health insurance segment.

The assigned ratings reflect Ping An Health’s sound risk-adjusted capitalization under recent capital strengthening, its diversified distribution channels (including affiliates’ distribution platforms and third-party online distribution channels), and the financial flexibility it receives from its two major shareholders, including public financial guarantees. The ratings also benefit from the business and operational support Ping An Group provides to Ping An Health, which plays an important role in the group’s strategy.

Offsetting rating factors include historical weak operating performance due to intense market competition, the execution risk of an ambitious business plan, and the pricing risk from target growth products’ underlying loss ratio assumptions due to a short history of product experience.

Positive rating actions could occur if Ping An Health can turn around its negative underwriting performance and continuously demonstrate stable and favorable operating results. Negative rating actions could occur if Ping An Group reduces the level of support to Ping An Health or Ping An Health’s risk-adjusted capitalization declines sharply due to a material operating loss.

Ratings are communicated to rated entities prior to publication. Unless stated otherwise, the ratings were not amended subsequent to that communication.

This press release relates to Credit Ratings that have been published on A.M. Best’s website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see A.M. Best’s Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Understanding Best’s Credit Ratings. For information on the proper media use of Best’s Credit Ratings and A.M. Best press releases, please view Guide for Media – Proper Use of Best’s Credit Ratings and A.M. Best Rating Action Press Releases.

A.M. Best is the world’s oldest and most authoritative insurance rating and information source. For more information, visit www.ambest.com.

Copyright © 2017 by A.M. Best Rating Services, Inc. and/or its subsidiaries. ALL RIGHTS RESERVED.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170802006203/en/

CONTACT

A.M. Best
Christie Lee, +852 2827 3413
Director,
Analytics

christie.lee@ambest.com
or
Moungmo
Lee, +65 6589 8412

Managing Director, Analytics
moungmo.lee@ambest.com
or
Christopher
Sharkey, +1 908-439-2200, ext. 5159

Manager, Public Relations
christopher.sharkey@ambest.com
or
Jim
Peavy, +1 908-439-2200, ext. 5644

Director, Public Relations
james.peavy@ambest.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • 新研究调查Masimo SpHb®在术后红细胞(RBC)输血最佳实践中的功用
  • 宝洁公司收购德国达姆施塔特默克集团的消费者健康业务
  • MOLOGEN AG: Collaboration with licensing partner ONCOLOGIE gains momentum
  • Vaxart Announces $5 Million Inavir® Revenue Milestone
  • 和铂医药与科伦博泰开展全球合作,共同开发多个创新全人源抗体药物